Physician profile
Alejandro R Singer
NPI 1982656997
$696.85
in general payments reported to CMS, 2019-2025
15 companies · $56.06 in 2025
The $56.06 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $156 · 2021: $38.87 · 2023: $136 · 2024: $39.20 · 2025: $56.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $247.76 | 2019-2021 | |
| Myriad Women'S Health, INC. | $135.55 | 2023 | Myrisk |
| Organon LLC | $57.82 | 2024-2025 | Nexplanon |
| Therapeuticsmd, INC. | $38.48 | 2019-2020 | |
| Amgen INC. | $30.84 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $30.18 | 2019 | |
| Merck Sharp & Dohme LLC | $24.93 | 2019-2020 | |
| Avion Pharmaceuticals | $24.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.53 | 2025 | |
| Duchesnay USA Incorporated | $17.07 | 2019 | |
| Exeltis, USA INC. | $13.91 | 2024 | Slynd |
| Lupin INC. | $13.86 | 2019 | |
| Acessa Health INC. | $13.52 | 2019 | |
| Allergan, INC. | $12.93 | 2019 | |
| Hologic Sales and Service, LLC | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.